Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Post-Exertional Malaise and the Biology of Energy Failure, 2026, Szafraniec

Dolphin

Senior Member (Voting Rights)
Free fulltext:

SZAFRANIEC, Artur, KRĘŻEL, Olga, KRĘŻEL, Maciej, KALINOWSKA, Zuzanna, ALEKSANDROWICZ, Hanna and RYBIŃSKA, Marcelina. Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS): Post-Exertional Malaise and the Biologyof Energy Failure. Journal of Education, Health and Sport. 2026;88:69423. eISSN 2391-8306. https://doi.org/10.12775/JEHS.2026.88.69423

Keywords​

Chronic fatigue, chronic infections, APT, Immune dysregulation, Post-exertional malaise, Neuroendocrine system

Abstract​

Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) is a severe, heterogeneous multisystem disorder defined by persistent fatigue lasting ≥6 months that is disproportionate to exertion, not relieved by rest, and associated with substantial functional decline.

Its hallmark feature is post-exertional malaise (PEM), a delayed and prolonged worsening of symptoms after minimal physical or cognitive effort.

Common symptoms include unrefreshing sleep, cognitive impairment, pain, flu-like complaints, sensory hypersensitivity, and autonomic dysfunction such as orthostatic intolerance.

Diagnosis is clinical and requires exclusion of alternative medical and psychiatric conditions, with commonly used frameworks including the CDC/Fukuda and International Consensus Criteria.

Evidence supports a multifactorial pathophysiology involving immune dysregulation, metabolic and mitochondrial abnormalities, neuroendocrine disturbance, gut dysbiosis, and autonomic dysfunction - collectively suggesting impaired energy homeostasis.

No validated biomarker exists, though multi-omic immune and metabolic signatures remain under investigation.

Management is supportive, emphasizing individualized pacing and treatment of comorbidities.
 
I think this is a student paper.
I'm not sure given that the authors are in different departments/similar:

Artur Szafraniec1 ORCID: https://orcid.org/0000-0002-9991-2039
E-mail: aszafraniec15@gmail.com
1Lower Silesian Centre for Oncology, Pulmonology and Haematology, plac Hirszfelda 12, 53-413 Wrocław

Olga Krężel2 ORCID:
E-mail: olgkrezel@gmail.com
2 4. Military Clinical Hospital and Polyclinic IPHC Weigla 5, 53-114 Wrocław

Maciej Krężel3 ORCID:
E-mail: mackrezel@gmail.com
3Wroclaw University of Science and Technology, Wybrzeże Stanisława Wyspiańskiego 27, 50-370 Wrocław
2

Hanna Aleksandrowicz1 ORCID: https://orcid.org/0009-0006-3686-3942
E-mail: hania.aleks24@gmail.com
1Lower Silesian Centre for Oncology, Pulmonology and Haematology, plac Hirszfelda 12, 53-413 Wrocław

Zuzanna Kalinowska1 ORCID: https://orcid.org/0009-0005-3940-3987
E-mail: zsujankalinowska@gmail.com
1Lower Silesian Centre for Oncology, Pulmonology and Haematology, plac Hirszfelda 12, 53-413 Wrocław

Marcelina Rybińska2 ORCID:
E-mail: marcelina.rybinska@gmail.com
2 4. Military Clinical Hospital and Polyclinic IPHC Weigla 5, 53-114 Wrocław
 
That abstract is actually a pretty good and concise summary, especially if it is a student paper. :thumbup:

Apart from the heterogeneous multisystem, and multifactorial pathophysiology bits, which or may not be true, we just don't know enough yet to confidently make such statements.

Take those out and it would be hard to improve much on it.

The message is slowly getting through, to those who wish to hear it.
 
Back
Top Bottom